[Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].

to establish a feasible and effective CART-based solid tumor therapy model. Therefore, we summarized the advances, challenges and possible solutions for CAR T therapy to treat solid tumors, and then prospected in the future clinical treatment.